These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4697143)

  • 1. [Rheological study of suppository bases with special reference to their consistency].
    Regdon G; Mezey G; Regdon G
    Acta Pharm Hung; 1973 Mar; 43(2):57-66. PubMed ID: 4697143
    [No Abstract]   [Full Text] [Related]  

  • 2. [Formulation of diazepam suppositories, results of rheological and biopharmaceutical studies. 1. Rheological study of the used suppository bases].
    Erós I; Bácskay I; Regdon G; Selmeczi B
    Acta Pharm Hung; 1993 Sep; 63(5):267-75. PubMed ID: 8249611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The determination of solubility and solubility rate of drugs in melted suppository masses].
    Pflegel P; Schöbel H
    Pharmazie; 1987 Aug; 42(8):551-2. PubMed ID: 3432339
    [No Abstract]   [Full Text] [Related]  

  • 4. Study on stability of drugs in lyophilic suppository bases. 3. Isolation of cyclovegantine, ethionamide and euphyllin degradation products from suppositories.
    Cieszyński T
    Acta Pol Pharm; 1972; 29(1):75-83. PubMed ID: 5055291
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of rheological properties of suppository suspension of Osarcyd].
    Perz S; Elsnerowa Z; Smigielska M
    Acta Pol Pharm; 1967; 24(6):587-93. PubMed ID: 6083087
    [No Abstract]   [Full Text] [Related]  

  • 6. [RHEOLOGICAL EXAMINATION OF SOME SUPPOSITORY BASES].
    KEDVESSY G; REGDON G; SZANTO F; GILDE FARKAS M
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1963 Dec; 33():837-44. PubMed ID: 14217980
    [No Abstract]   [Full Text] [Related]  

  • 7. [Method for the determination of the solubility of drugs in ointment and suppositories bases].
    Mayer A; Kata M
    Pharmazie; 1973 Mar; 28(3):214-5. PubMed ID: 4700929
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on pharmaceutical drug design for suppositories. II. Rheological properties of emulsion-type suppository bases.
    Noro S; Komatsu Y; Uesugi T
    Chem Pharm Bull (Tokyo); 1982 Aug; 30(8):2906-11. PubMed ID: 7139833
    [No Abstract]   [Full Text] [Related]  

  • 9. [Stability of drugs in lyophilic suppository bases. V. Identification of products of ethionamide decay isolated from suppositories].
    Cieszyński T
    Acta Pol Pharm; 1974; 31(5):651-6. PubMed ID: 4447018
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of surfactant characteristics on drug availability from suppositories.
    Realdon N; Dal Zotto M; Morpurgo M; Franceschinis E
    Pharmazie; 2008 Jun; 63(6):459-63. PubMed ID: 18604990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The determination of the real dissolution rate of drug substances in melted suppository masses].
    Schöbel H; Klaus T; Raguse U; Pflegel P
    Pharmazie; 1988 Sep; 43(9):650-1. PubMed ID: 3244737
    [No Abstract]   [Full Text] [Related]  

  • 12. [Kinetics of drug degradation. VI. Kinetics of degradation of phenylbutazone (FB) in suppository bases].
    Pawelczyk E; Zajac M
    Acta Pol Pharm; 1970; 27(2):113-7. PubMed ID: 5422244
    [No Abstract]   [Full Text] [Related]  

  • 13. Preformulation studies on suppositories by thermal methods.
    Giordano F; La Manna A; Bettinetti GP; Zamparutti M
    Boll Chim Farm; 1990 Apr; 129(4):160-5. PubMed ID: 2245004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro release of meclozine hydrochloride from lipophilic suppository bases with or without tensides.
    Bećirević M; Petricić V; Kallay N
    Pharmazie; 1984 Dec; 39(12):828-30. PubMed ID: 6531391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Consistence studies on suppository-bases containing TWEEN-61].
    Regdon G; Regdon E; Mezey G
    Arch Pharm (Weinheim); 1973 Aug; 306(8):572-9. PubMed ID: 4763864
    [No Abstract]   [Full Text] [Related]  

  • 16. [The dynamics of the drug release from suppositories. Part 5: Liberation of chlorpromazine from suppository bases (author's transl)].
    Pasich J; Drobnicka B; Kasprzyk A
    Pharmazie; 1981; 36(1):20. PubMed ID: 7220580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the action of various factors on the liberation from suppositories (author's transl)].
    Bornschein M; Grohmann A; Voigt R
    Pharmazie; 1980 Dec; 35(12):772-6. PubMed ID: 7208579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of fatty acid composition on the properties and polymorphic transition of fatty suppository bases.
    Yoshino H; Kobayashi M; Samejima M
    Chem Pharm Bull (Tokyo); 1983 Jan; 31(1):237-46. PubMed ID: 6850937
    [No Abstract]   [Full Text] [Related]  

  • 19. [Liberation of active substances from suppository bases. II. In vivo studies of phenobarbital suppositories].
    Grzesiczak A; Ludwicki H; Ostrowska E
    Acta Pol Pharm; 1981; 38(4):493-7. PubMed ID: 7331837
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies of consistency in lipophilic bases of suppositories and of drug-containing suppositories. 2. Determination of skittle flow point, of breaking strength of time of disintegration].
    Regdon G; Mezey G; Sztankovánszky K
    Pharmazie; 1973 Jul; 28(7):461-4. PubMed ID: 4767496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.